middle.news
How Will Osteopore’s New Bone Filler Deal Transform Its Southeast Asia Strategy?
9:36am on Thursday 12th of March, 2026 AEDT
•
Healthcare
Read Story
How Will Osteopore’s New Bone Filler Deal Transform Its Southeast Asia Strategy?
9:36am on Thursday 12th of March, 2026 AEDT
Key Points
Non-exclusive distribution rights secured from dsm-firmenich for Southeast Asia
Injectable bone filler complements Osteopore’s existing orthopaedic products
Agreement spans three years with minimum order commitments
Southeast Asia orthobiologics market valued up to AUD 284 million and growing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Osteopore (ASX:OSX)
OPEN ARTICLE